EX-10.11 13 d657877dex1011.htm EX-10.11 PLATFORM AGREEMENTPlatform Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionTHIS PLATFORM AGREEMENT (“Agreement”), dated as of June 23, 2009 (the “Effective Date”), is by and between CALANDO PHARMACEUTICALS, INC., a Delaware corporation having its principal place of business at 129 North Hill Avenue, Pasadena, California 91106 (hereinafter referred to as “Calando”), and CERULEAN PHARMA INC., a Delaware corporation, having its principal place of business at 161 First Street, Cambridge, Massachusetts 02142 (hereinafter referred to as “Cerulean”).
PLATFORM AGREEMENTPlatform Agreement • January 30th, 2014 • Cerulean Pharma Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 30th, 2014 Company Industry JurisdictionConfidential materials omitted and filed separately with the Securities and Exchange Commission. A total of three pages were omitted. [**]